HOME >> BIOLOGY >> NEWS
Long-Time NIH Grantee Wins Nobel Prize In Chemistry

Dr. Paul D. Boyer, a long-time NIH grantee, is one of three recipients of the 1997 Nobel Prize in chemistry. Boyer, who is a professor emeritus of biochemistry at the University of California, Los Angeles, received over $4.4 million in research grant support from NIH between 1948 and 1996. The vast majority of this support was from the National Institute of General Medical Sciences, with other funding coming from the National Institute of Diabetes and Digestive and Kidney Diseases.

Dr. Jens C. Skou of Aarhus University in Denmark, one of the other prize recipients, received support from NIH's National Institute of Neurological Disorders and Stroke in the early 1960's.

"The Nobel Prize recognizes Dr. Boyer for a lifetime spent investigating the molecular mechanism by which ATP--the cellular energy that drives all biological reactions--is formed," said Dr. Marvin Cassman, NIGMS Director. "Determining how ATP is synthesized has been a central problem in biology for decades and is at the core of an understanding of metabolic processes in the cell. Dr. Boyer has been a key contributor to the molecular understanding of ATP synthesis."

Since the early 1950's, Boyer has sought to understand the inner workings of ATP synthase, the enzyme he calls the "splendid molecular machine" that produces ATP. The enzyme is a complex protein rooted in the inner membranes of cellular structures called mitochondria, the "powerhouses of the cell."

Over several decades, Boyer developed a model of how the various subunits of the enzyme work together like gears, levers, and ratchets to generate cellular e
'"/>

Contact: Alisa Zapp or Ann Dieffenbach
pub_info@nigms.nih.gov
301-496-7301
NIH/National Institute of General Medical Sciences
15-Oct-1997


Page: 1 2

Related biology news :

1. Press workshop Life, a Nobel Story
2. Structure of a Nobel-prize winning molecule: Aquaporin
3. Marie Curie Nobel Centennial Celebration of Women in Science
4. Roderick MacKinnon wins 2003 Nobel Prize in Chemistry
5. Illinois professor wins Nobel Prize
6. UT Southwestern Nobelists find protein structure that may help fight high cholesterol
7. Kurt Wthrich of The Scripps Research Institute wins 2002 Nobel Prize in Chemistry
8. Sydney Brenner, Molecular Sciences Institute founder, awarded the Nobel Prize
9. Salk Institute professor Sydney Brenner receives 2002 Nobel Prize for medicine
10. NLM exhibit features Nobelist Joshua Lederberg
11. Günter Blobel wins 1999 Nobel Prize for physiology or medicine

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Long Time NIH Grantee Wins Nobel Prize Chemistry

(Date:2/13/2015)... 13, 2015 ACT Genomics Co., Ltd., ... to transform cancer genomic information into precision diagnosis ... has raised US$ 8 million in the its first ... Taipei, Taiwan , ACT Genomics has ... the aim to implement next generation sequencing (NGS) ...
(Date:2/10/2015)... -- Alere Inc. (NYSE: ALR), a global leader in ... quarter ended December 31, 2014. Namal ... said, "We made substantial progress in the fourth ... in rapid diagnostics and delivering against our financial ... early January enabled us to substantially reduce our ...
(Date:2/5/2015)...   Epic Sciences , a precision diagnostics company dedicated ... Murali Prahalad , Ph.D., president and CEO, is scheduled to ... 2015: Silicon Valley, which is taking place at the Computer ... on January 26-28, 2015. Dr. Prahalad will ... Last year, Epic Sciences was a finalist in the PMWC,s ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35
(Date:2/26/2015)... -- S&P Capital IQ (MHFI) announced today that it ... Therapeutics Holdings Inc . MabVax Therapeutics ... focused on the development of vaccine and antibody-based therapies ... cancer. MabVax has discovered a pipeline of human monoclonal ... by patients who have been immunized against targeted cancers. ...
(Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading ... Kate Black as Privacy Officer and Corporate Counsel. ... state privacy laws as well as health care regulations. ... she will be responsible for reviewing, updating and enhancing ... the U.S. and abroad. She joined the company January ...
(Date:2/26/2015)... 26, 2015   Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today reported ... goals, other key objectives, and financial guidance.  Synageva,s ... at 4:30 p.m. EST to review the financial ... participate in today,s call by telephone, please dial ...
(Date:2/26/2015)... , Feb. 26, 2015 Protiviti ( ... latest version of the Governance Portal , designed ... risk and compliance (GRC) tasks across multiple business units ... updated to help customers better align their controls with ... Treadway Commission ) requirements. In response to client feedback, ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 523andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
Cached News: